ClinicalTrials.Veeva

Menu

Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms (HDAX1)

I

Inner Group

Status

Unknown

Conditions

Chronic Disease
Multiple Sclerosis
Trauma, Psychological
Trauma
Restless Legs Syndrome

Treatments

Behavioral: Direct Autonomic Experience Control
Behavioral: Self-Hypnosis

Study type

Observational

Funder types

Industry

Identifiers

NCT04303143
HypDax1

Details and patient eligibility

About

Study will look at a limited number of participants with various chronic symptoms. Investigating a new and novel form of hypnosis application called "Direct Autonomic Experience (DAX)" which is using combination of visualization, metaphor, post-hypnotic suggestion and anchoring.

Purpose is to confirm that DAX generally appears to impact SUDS value and subjects report observed level of effect on short and longer term measurements.

Most significantly, testing that DAX technique/action is reusable later if the measured SUDS value returns or increases.

Full description

Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms One common characteristic of many chronic conditions is the neurology/ biology/ symptomology may change slightly or signficantly over time. So an initial process/plan that worked well for affecting a SUDS discomfort level, may no longer work or work as well.

DAX is designed to be adaptive such that as matters that affected the initial SUDS conditions may have changed, shifted, grown or otherwise be different.

(Examples are increased lesions with MS). Where initial patterns were created with a certain set of neural condition and pathways. But now days/weeks later, with new pathways created, can a previously installed DAX pattern adjust and shift to accommodate the new neural patterns based on participants willingness and self-instruction, or does it require professional adjustment.

Example participant given strong post-hypnotic suggestions/anchor/etc to squeeze right hand in certain way to bring relief to leg discomfort. Initial testing shows working. Now time has shifted, maybe new pathways or other chronic conditions have changed. Can the DAX processes the participant has been taught handle these changes or does it require a professional to re-apply/boost or incorporate new details to get significant changes to reported SUDS discomfort values.

Enrollment

20 estimated patients

Sex

All

Ages

12+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participant must have a proper medical diagnosis of chronic condition.
  • Existing medical treatments are having little to no effect on a discomfort metric to measure
  • SUDS to be evaluated could be physical or emotional in nature (e.g. Anxiety level, or Leg Cramping/moving)
  • Must be motivated and willing to participate in a study that uses hypnosis, placebo and/or nocebo type mental matters.
  • Participant must continue existing medical treatments (as recommended/adjusted by such outside professionals) and continue to see and be monitored by new/existing medical professionals during the term of study.
  • Must have technology of computers/internet/support to be able to attend regular video chat/conferences for needed interactions with study.
  • Must have schedule availability and flexibility to meet in video chats/conferences as required.
  • Must have the computer skills/resources and aptitude to handle video chat/conference and able to have resources/friends/knowledge that can help if technical issues arise to allow conference to occur (can handle restarting a video conference if crashes or network acts up)

Exclusion criteria

  • Acute and short term discomfort matters not being measured that outside scope of chronic condition.
  • Must not be active in any other studies or such studies deemed to not interact with this.
  • Does not have a properly diagnosed chronic condition (exception are control subjects)

Trial design

20 participants in 1 patient group

Primary
Description:
Primary
Treatment:
Behavioral: Self-Hypnosis
Behavioral: Direct Autonomic Experience Control

Trial contacts and locations

0

Loading...

Central trial contact

Martin Vendemia, BCH, MNLP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems